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Abstract: In this work a series of 15 N-benzylamine substituted 5-amino-6-methyl-
pyrazine-2,3-dicarbonitriles was prepared by the aminodehalogenation reactions using 
microwave assisted synthesis with experimentally set and proven conditions. This 
approach for the aminodehalogenation reaction was chosen due to its higher yields and 
shorter reaction times. The products of this reaction were characterized by IR, NMR and 
other analytical data. The compounds were evaluated for their antibacterial, antifungal and 
herbicidal activity. Compounds 3 (R = 3,4-Cl), 9 (R = 2-Cl) and 11 (R = 4-CF3) showed 
good antimycobacterial activity against Mycobacterium tuberculosis (MIC = 6.25 µg/mL). 
It was found that the lipophilicity is important for antimycobacterial activity and the best 
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substitution on the benzyl moiety of the compounds is a halogen or trifluoromethyl group 
according to Craig’s plot. The activities against bacteria or fungi were insignificant. The 
presented compounds also inhibited photosynthetic electron transport in spinach 
chloroplasts and the IC50 values of the active compounds varied in the range from 16.4 to 
487.0 µmol/L. The most active substances were 2 (R = 3-CF3), 3 (R = 3,4-Cl) and 11  
(R = 4-CF3). A linear dependence between lipophilicity and herbicidal activity  
was observed. 
Keywords: pyrazinamide derivatives; in vitro biological evaluation; microwave-assisted 
synthesis; tuberculosis; lipophilicity 
 
1. Introduction 
Mycobacterium tuberculosis is counted with justification among the most dangerous and successful 
microorganisms in today’s world, especially in developing countries which have become the reservoir 
of resistant strains (the most burdened countries are in South Africa and East Asia) [1]. These strains 
are causing the biggest number of problems connected to tuberculosis (TB) treatment [2]. The main 
problem is resistance. It can be divided into three groups. The first one is called multidrug-resistant TB 
(MDR-TB) and these microbes are resistant to all first-line antituberculotic drugs (pyrazinamide - PZA, 
isoniazid - INH, rifampicin - RIF, ethambutol - ETH, streptomycin - STR). The second group is more 
treacherous. This type of resistance is called extensively or extremely drug-resistant TB (XDR-TB) 
with the resistance to the first-line anti-TB agents isoniazid and rifampicin together with the resistance 
to any fluoroquinolone used in the therapy and to at least one of three injectable second-line 
antituberculotic drugs (amikacin, kanamycin or capreomycin) [3]. The last and the latest category was 
the most dreaded and was called totally drug-resistant TB (TDR-TB) and the first case was recorded in 
India [4]. These mycobacterial strains were resistant to all current known therapy. Nowadays, this 
group has disappeared with the approval of bedaquiline for therapy of resistant forms of tuberculosis. 
Another problem is connected with the HIV pandemic. These two infectious diseases are influencing 
each other in a synergic way so this has resulted in efforts to develop new anti-tubercular agents. 
This work deals with a microwave-assisted synthesis of pyrazinamide analogues with potential 
antimycobacterial activity. It is caused by the fact that pyrazinamide is counted among the first-line 
anti-tuberculosis drugs used in current therapy. Its unique ability to kill the dormant forms of 
Mycobacterium tuberculosis is crucial in shortening the time needed for the treatment, so PZA has 
sterilizing activity especially in combination with rifampicin [5]. 
PZA itself has multiple mechanisms of action. The first described was the activation of this prodrug 
via the enzyme pyrazinamidase (EC 3.5.1.19) to form pyrazinoic acid (POA). This metabolite causes a 
lowering of the inner compartment pH in mycobacterial cells. This leads to inhibition of membrane 
transport and then to cellular death [6–8]. The gene encoding this enzyme is called pncA gene and its 
mutation is responsible for the origin of mycobacterial resistance to PZA [9]. 
The second mechanism of action is connected with fatty acid synthase I (FAS I) (EC 2.3.1.85). It is 
suggested that the disruption of metabolism can be caused by inhibition of the cell membrane 
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synthesis, which is essential for the survival of Mycobacteria, but this mechanism was mainly rejected 
for PZA itself by Boshoff because there is only low inhibition [10]. On the other hand, the PZA 
analogues such as 5-chloropyrazinamide, esters of pyrazinoic acid and esters of 5-chloropyrazinoic 
acid were proven to act in this way [11–13]. 
Recent research has suggested a novel mechanism of action of PZA - inhibition of trans-translation. 
This process is vital for survival and virulence of Mycobacteria and its inhibition leads to blockage of the 
proteosynthetic apparatus in ribosomes and to cellular death. These assumptions were proven by  
Zhang et al. [14]. 
Although PZA is the first-line antituberculotic drug, it was found that this molecule has exhibited 
other interesting biological activities such as antifungal, antibacterial, antiviral and antineoplastic  
effects [15–20]. 
There is another application of PZA derivatives that can be used in agriculture. The most successful 
pyrazine derivative diquat-dibromide (6,7-dihydrodipyrido[1,2-a:2',1'-c]pyrazinediium-dibromide),  
a non-selective, contact herbicide, which has been used to control many submerged and floating 
aquatic macrophytes, was found to interfere with the photosynthetic process by releasing strong 
oxidizers that rapidly disrupt and inactivate cells and cellular functions (at present banned in many EU 
countries) [21]. Many structural variations of pyrazine compounds with herbicidal properties can be found 
in the patent literature [22–25]. However, several pyrazine derivatives were also described as inhibitors of 
Hill reaction which inhibit photosynthetic electron transport (PET) in photosystem (PS) 2 [18,26].  
The site of action of these PET inhibitors in the photosynthetic apparatus was situated predominantly 
on the donor side of PS2, in the section between oxygen evolving complex and intermediate D,  
i.e., tyrosine radical (TyrD•) occurring on the 161st position in D2 protein. Consequently, these 
compounds can be considered as PS2 herbicides which could have ultimately adverse effect on plant 
growth. In general, the PET-inhibiting effectiveness of pyrazine derivatives depends on compound 
lipophilicity and σ Hammett constants of individual substituents. Hosseini et al. studied the electronic 
and structural descriptors, which are the main factors for the cytotoxicity in the series of substituted  
N-phenylpyrazine-2-carboxamides [27]. 
This study is focused on preparation of N-substituted structural and functional derivative of PZA  
(5-chloro-6-methylpyrazine-2,3-dicarbonitrile) that was treated with ring-substituted benzylamines 
using the advantages of a microwave reactor. It should be stressed that this type of syntheses has 
become popular due to its higher yields, shorter reaction times or solvent savings in comparison with 
conventional organic syntheses [28]. One of the main advantages is the heating. It is uniform through 
the volume of the sample and the microwaves usually interact with molecules themselves not vessel 
sides. Another benefit is connected with the temperature reached by the solvent used. The final 
temperature is usually far higher than the standard boiling point of the solvent when using over- 
pressurized systems. It is reached and bypassed in seconds. Improved heating usually leads to higher 
yields and shorter reaction times. There is one limitation for choosing the conditions. It is the polarity 
of the solvent when the non-polar solvents cannot be used in the way the polar ones can be. If the polar 
solvent is used in the reaction, there is a direct coupling of microwaves with molecules. More polar 
solvents have greater ability to interact with microwave radiation. Using the solvents with low polarity 
(low absorbers) leads to longer times of heating and reaction. On the contrary, if the reagents 
themselves are polar it could lower the disadvantages of non-polar solvents. Finally there are new 
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approaches to microwave accelerated methods using ionic liquids or solid phase reactions (adsorption 
on mineral oxides, phase transfer catalysis, neat reactions) [29]. Microwave assisted condensation in 
polar solvent is used in this work to accelerate the aminodehalogenation reaction. The conditions for 
the synthesis were proven experimentally. Antimycobacterial activity of the all prepared compounds 
was determined and compounds were evaluated also in relation to inhibition of photosynthetic electron 
transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. The structure-activity relationships 
between the chemical structure and in vitro biological activities of evaluated compounds are discussed. 
2. Results and Discussion 
2.1. Chemistry  
The starting compound 5-chloro-6-methylpyrazine-2,3-dicarbonitrile and the final compounds 1–15 
were synthesized according to the general procedure shown in Scheme 1. The aminodehalogenation 
reaction of this starting compound and ring-substituted benzylamines yielded a series of 15 secondary 
amines of which 14 were novel. 5-(Benzylamino)-6-methylpyrazine-2,3-dicarbonitrile (6) was 
previously synthesised by Takematsu et al. and the reported melting point was 118–119 °C [30]. The 
compound we obtained melted at 128.7–130.7 °C. This difference can be caused by the mode of 
crystallization. All reactions were done using microwave reactor with focused field and yields were in 
the range between 17% and 62%. Lower yields were caused by the purification using preparative 
chromatography and recrystallization. It is also known that 3-nitro substitution, for which the yield was 
the lowest, is counted among the electron-withdrawing groups reducing the basicity of the amine 
nitrogen. Obtained analytical data were fully consistent with the proposed structures. Table 1 shows the 
substituents and other data of the synthesized compounds. 
Scheme 1. Synthesis of starting compound [30] and microwave assisted aminodehalogenation 
reaction resulting in a series of compounds 1–15. 
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Table 1. Experimentally determined values of lipophilicity log k, calculated values of log P, 
electronic Hammett’s σ parameters and π parameters, 50% inhibition concentration  
IC50 [μmol/L] values related to PET inhibition in spinach chloroplasts in comparison with 
3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard and in vitro antimycobacterial 
activity against M. tuberculosis H37Rv (minimal inhibition concentration (MIC) [μg/mL]) 
of compounds 1–15 compared to pyrazinamide (PZA) and isoniazid (INH) standards. 
Compound R log P log k σ π IC50 
[μmol/L]
MIC M.tuberculosis 
H37Rv [μg/mL] 
1 2-CH3 3.41 0.4668 −0.17 0.1674 114.0 >100 
2 3-CF3 3.84 0.5369 0.43 0.2375 37.7 12.5 
3 3,4-Cl 4.04 0.7538 0.60 0.4544 16.4 6.25 
4 4-CH3 3.41 0.5157 −0.17 0.2163 104.7 25 
5 4-OCH3 2.8 0.2820 −0.27 −0.0174 464.6 >100 
6 H 2.92 0.2994 0 0 - 25 
7 4-NH2 2.12 −0.2014 −0.15 −0.5008 - 25 
8 3-Cl 3.48 0.5172 0.37 0.2178 57.4 12.5 
9 2-Cl 3.48 0.4663 0.22 0.1669 79.0 6.25 
10 2-F 3.08 0.3042 0.06 0.0048 195.6 12.5 
11 4-CF3 3.84 0.5626 0.51 0.2632 39.6 6.25 
12 2-CF3 3.84 0.4865 0.51 0.1871 71.6 12.5 
13 2,4-OCH3 2.67 0.3699 −0.55 0.0705 - 25 
14 3-NO2 2.71 0.1808 0.71 −0.1186 487.4 12.5 
15 4-Cl 3.48 0.5384 0.23 0.2390 86.5 12.5 
PZA      - 12.5 
INH      - 1.5625 
DCMU      1.9 - 
π = log k(substituted) – log k(unsubstituted). 
2.2. Calculated and Experimentally Set Lipophilicity  
Lipophilicity is one of the most important factors that can affect the biological effect of the 
compound. It is connected with the membrane transport and other biological processes and it is also 
connected with solubility in the media. This physical-chemical property can be set experimentally. In 
this work we have used the Reversed Phase - High Performance Liquid Chromatography (RP-HPLC) 
methodology for measuring the capacity factors k with the calculation of log k that can be correlated to 
calculated values of lipophilicity log P (resp. Clog P). These calculations were carried out by using PC 
program CS ChemBioDraw Ultra 13.0. The results of these measurements are shown in the Table 1. 
The lowest lipophilicity was shown by compound 7 (R = 4-NH2) and on the contrary, compound 3 
(R = 3,4-Cl) was the most lipophilic compound of this series. Lipophilicity, based on log k values, 
increased for substituents in the benzyl part of the molecule as follows: 4-NH2 < 3-NO2 < 4-OCH3 < H 
< 2-F < 2,4-OCH3 < 2-Cl < 2-CH3 < 2-CF3 < 4-CH3 < 3-Cl < 3-CF3 < 4-Cl < 4-CF3 < 3,4-Cl  
The dependence of the measured log k parameters on the calculated log P values showed an 
approximate linearity, which is shown in Figure 1, and the corresponding correlation can be expressed 
by the following regression equation: 
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log k = −0.810 × (±0.150) + 0.371 × (±0.045) × log P 
r = 0.915, s = 0.092, F = 66.9, n = 15 
(1)  
Figure 1. Plot of experimentally measured log k parameter on calculated log P (CS 
ChemBioDraw Ultra version 13.0). 
 
2.3. Biological Assays 
2.3.1. Antimycobacterial In Vitro Screening 
All prepared compounds were tested against four strains of Mycobacterium. These were  
M. tuberculosis and three non-tuberculosis strains. The most active substances against M. tuberculosis 
were compounds 3, 9 and 11. Their activity expressed as minimal inhibition concentration (MIC) was 
6.25 µg/mL and the activities of standards were 12.5 µg/mL for PZA and 1.5625 µg/mL for INH. 
Nearly the whole series showed activity against M. tuberculosis H37Rv, which was in the range from 
25 to 6.25 µg/mL, but compounds 11 and 12 were also active against other strains and both of them 
were active against M. avium 152. These strains are usually resistant or unsusceptible to pyrazinamide. 
This is the reason why INH was chosen as second standard. Obtained results can be compared with 
other synthesised compounds and a comparison can be drawn between more mycobacterial strains not 
only M. tuberculosis. 
As shown in Figure 2, dependence of antimycobacterial activity on lipophilicity expressed by π 
constant (log k) as well as on the σ constant of the R substituent was observed. The most active 
compounds (MIC = 6.25 µg/mL) were 3 (R = 3,4-Cl), 9 (R = 2-Cl) and 11 (R = 4-CF3) and were 
mentioned above. All of these compounds are situated in the right upper quadrant of the Craig’s plot. 
Further groups are represented by compounds 2 (R = 3-CF3), 8 (R = 3-Cl), 10 (R = 2-F), 12 (R = 2-CF3), 
14 (R = 3-NO2) and 15 (R = 4-Cl) showing moderate activity with MIC = 12.5 µg/mL and compounds 
4 (R = 4-CH3), 6 (R = H), 7 (R = 4-NH2) and 13 (R = 2,4-OCH3) with MIC = 25 µg/mL. Low 
antimycobacterial activity with MIC >100 µg/mL was exhibited by compounds 1 (R = 2-CH3) and 5  
(R = 4-OCH3). It can be stated that the activity is more dependent on π constant than on σ constant.  
On the other hand this dependence is not unambiguous. However, it is clear that the lipophilicity is 
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important for antimycobacterial activity and the most suitable ring substituents are electron-withdrawing 
groups such as halogen or trifluoromethyl moieties. 
Figure 2. Dependence of antimycobacterial activity of studied compounds on the π 
constant (log k) as well as on the σ constant of R substituent. 
 
2.3.2. Antimycobacterial In Vitro Screening Against M. smegmatis 
This evaluation was performed against fast-growing Mycobacterium smegmatis using isoniazid and 
ciprofloxacin as standards. None of the compounds showed activity against this mycobacterial strain. This 
may be caused by the fact that this fast-growing mycobacterium is less susceptible to antibiotic treatment. 
2.3.3. Antifungal and Antibacterial In Vitro Screening 
This evaluation was performed in order to obtain results for antifungal and antibacterial activity 
against eight fungal strains and eight bacterial strains. None of the prepared compounds showed 
antibacterial activity against the tested strains. On the contrary, compounds 7 (MIC = 500 µmol/L),  
10 (MIC = 500 µmol/L) and 12 (MIC = 125 µmol/L) exhibited activity against Trichophyton 
mentagrophytes but in comparison to standards, this activity was negligible. It can be also caused by 
the bigger susceptibility of this fungal strain being evaluated. 
2.3.4. Herbicidal Activity of Prepared Compounds 
The studied compounds inhibited photosynthetic electron transport in spinach chloroplasts (Table 1). 
The PET inhibiting activity of studied compounds 1–15 expressed by IC50 value varied from  
16.4 μmol/L (3) to 487.0 μmol/L (14). The inhibitory activity of the most active compounds 3 was 8.6 
times lower than that of the standard DCMU (IC50 = 1.9 μmol/L), a well-known PS2 herbicide. 
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Compounds 6 (R = H), 7 (R = 4-NH2) and 13 (R = 2,4-OCH3) were inactive and IC50 values related to 
PET inhibition could not be determined. It can be stated that the inhibitory activity increases linearly 
with increasing lipophilicity of the compounds based on the dependence of PET inhibiting activity of 
studied dicarbonitriles 1–15 on log P (Figure 3A) and log k (Figure 3B). 
Figure 3. Dependence of PET inhibiting activity on the log P (A) or log k (B) of 
compounds 1–15. 
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Also if compound 14 (R = 3-NO2) was excluded, the dependence of PET inhibiting activity on the 
Hammett constant σ of R substituent showed again linear dependence (Figure 4). A linear increase of 
PET-inhibiting activity was observed in the range of σ from -0.15 (7; R = 4-NH2) to 0.6 (3; R = 3,4-Cl). 
Figure 4. Dependence of PET inhibiting activity of compounds 1–15 on the σ constant of 
the R substituent. 
 
The correlation between log (1/IC50) [mol/L] and log P or between log (1/IC50) [mol/L] and σ 
constant of R substituent could be expressed by the following equations: 
pI50 = 0.577 × (± 0.882) + 1.002 × (± 0.250) log P 
r = 0.950, s = 0.127, F = 82.5, n = 11 
(2) 
A B 
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pI50 = 3.881 × (± 0.182) + 1.051 × (±0.503) σ 
r = 0.844, s = 0.217, F = 22.34, n = 11 
(3) 
The use of both the above mentioned descriptors (log P and σ) in a multilinear correlation did not 
improve the results of statistical analysis: 
pI50 = 0.949 × (± 1.669) + 0.887 × (± 0.504) log P + 0.160 × (± 0.594) σ 
r = 0.952, s = 0.131, F = 38.6, n = 11 
(4) 
Similarly, better results of statistical analysis were obtained for the correlation between log (1/IC50) 
[mol/L] and log k than for multilinear correlation using two descriptors (log k and σ). 
pI50 = 2.703 (±0.414) + 2.835 (±0.816) log k 
r = 0.934, s = 0.144, F = 61.8, n = 11 
(5) 
pI50 = 2.997 × (± 0.331) + 2.034 × (± 0.738) log k + 0.481 (0.303)  
r = 0.976 s = 0.093 F = 80.2 n = 11 
(6) 
These results indicate that lipophilicity of the compound is determining for PET-inhibiting activity 
of the studied N-substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles. Lee et al. focused on the 
search for the minimum structural requirements for herbicidal evaluation of 5-(R1)-6-(R2)-N-(R3-
phenyl)-pyrazine-2-carboxamide analogues as a new class of potent herbicides in a previous paper [31]. 
Based on IC50 values of 19 pyrazine derivatives related to PET inhibition in spinach chloroplasts which 
were published by Dolezal et al. [15], Lee derived and discussed quantitatively 3D-QSARs models 
between the substituents (R1–R3) changes of the analogues and their herbicidal activity using 
comparative molecular field analysis (CoMFA) and comparative molecular similarity indice analysis 
(CoMSIA) methods. It was predicted that the herbicidal activity increases when large steric 
substituents were introduced to one part of the ortho- and meta- positions on the N-phenyl ring as  
R3- substituent and small steric substituents on the other part. The same 19 pyrazine derivatives with 
herbicidal activity were also subjected to the two dimensional quantitative structure activity 
relationships studies using Vlife Molecular Design 3.0 module which contains various combinations of 
thermodynamic, electronic, topological and spatial descriptors [32]. It was found that decreasing of 
number of hydrogen bond acceptor atoms and reduction the any atoms (single, double or triple 
bonded) separated from any oxygen atom by a seven bond distance in a molecule could be helpful for 
designing more potent herbicidal agents. 
Because the studied N-substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles were found to 
inhibit the Hill reaction, they can be considered as photosystem 2 (PS2) inhibitors, i.e., PS2 herbicides 
which ultimately adversely affect growth of weeds as well as agricultural plants. The PS2 inhibitors 
can act on the donor and/or the acceptor side of PS2. Using EPR spectroscopy it was found that  
N-phenylpyrazine-2-carboxamides interacted with the D intermediate which is situated at 161st 
position in D2 protein occurring on the donor side of PS2. Due to interaction of these pyrazine 
derivatives with this part of PS2, the photosynthetic electron transport from the oxygen evolving 
complex to the reaction centre of PS2 was impaired and consequently, the electron transport between 
PS2 and PS1 was inhibited [33]. Use of an artificial electron-donor, 1,5-diphenylcarbazide (DPC), 
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acting in the Z/D intermediate is suitable to estimate whether the studied PET inhibitor acts only on 
the donor or also on the acceptor side of PS2. Complete restoration of PET after DPC addition to 
chloroplasts activity of which was inhibited by an inhibitor, indicates that PET between the core of 
PS2 (P680) and the secondary quinone acceptor QB was not affected by this inhibitor. Consequently, 
its site of inhibitory action is situated on the donor side of PS2. However, upon addition of DPC to the 
studied dicarbonitriles only partial restoration of PET was observed (up to 85% of the control) and 
therefore it could be assumed that the studied compounds block PET not only by interaction with 
proteins occurring in the section between the oxygen evolving complex (OEC) and the Z/D 
intermediate but to PET inhibition contributes also their interaction with some constituents of 
photosynthetic apparatus on the acceptor side of PS2. Similar results were obtained previously with  
5-tert-butyl-N-(3-hydroxy-4-chlorophenyl)pyrazine-2-carboxamide and 5-tert-butyl-6-chloro-N-(3-
fluorophenyl)pyrazine-2-carboxamide [33]. 
Compounds 1–15 affected the chlorophyll a (Chla) fluorescence in spinach chloroplasts. As shown 
in Figure 5, the intensity of the Chla emission band at 686 nm belonging to the pigment–protein 
complexes in photosystem 2 decreased in the presence of compound 3 [34]. This finding indicates a 
perturbation of the Chla–protein complexes in the thylakoid membrane caused by the tested 
compound. Similar Chla fluorescence decrease in spinach chloroplasts was observed previously  
with several PET inhibitors, i.e., N-benzylpyrazine-2-carboxamides [35], ring-substituted  
3-hydroxynaphthalene-2-carboxanilides [36] and 1-hydroxynaphthalene-2-carboxanilides [37],  
2-hydroxynaphthalene-1-carboxanilides [38] and ring-substituted 4-arylamino-7-chloroquinolinium 
chlorides [39]. 
Figure 5. Fluorescence emission spectra of Chla of untreated spinach chloroplasts and 
chloroplasts treated with 0, 0.13, 0.25 and 0.51 mmol/L of compound 3 (R = 3,4-Cl) (the curves 
from top to bottom); excitation wave length λ = 436 nm; chlorophyll concentration 10 mg/L. 
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3. Experimental 
3.1. General 
All the chemicals used for preparation of starting compound and final products were purchased 
from Sigma-Aldrich (Sigma-Aldrich, St. Louis, MO, USA) and were reagent or higher grade of purity. 
Starting compound was prepared according to proven methodology of conventional organic synthesis. 
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The final aminodehalogenation reactions were performed in CEM Discover microwave reactor with 
focused field (CEM Corporation, Matthews, NC, USA) connected to the Explorer 24 autosampler 
(CEM Corporation) and this equipment was running under CEM’s Synergy™ software for monitoring 
the progress of reactions. The reaction progress was checked by Thin Layer Chromatography (TLC) 
(Alugram® Sil G/UV254, Machery-Nagel, Postfach, Germany) using 254 nm wavelength UV 
detection. All the obtained products were purified by crystallization or by preparative flash 
chromatography (CombiFlash® Rf, Teledyne Isco Inc., Lincoln, NE, USA), using gradient elution with 
hexane (LacheNer, Neratovice, Czech Republic) and ethyl acetate (Penta, Prague, Czech Republic) as 
mobile phases. Silica gel (0.040–0.063 nm, Merck, Darmstadt, Germany) was used as the stationary 
phase. NMR spectra were recorded on Varian Mercury–VxBB 300 (299.95 MHz for 1H and  
75.43 MHz for 13C) or Varian VNMR S500 (499.87 MHz for 1H and 125.71 MHz for 13C) 
spectrometers (Varian Corporation, Palo Alto, CA, USA). Chemical shifts were reported in ppm (δ) 
and were applied indirectly to tetramethylsilane as a signal of solvent (2.49 for 1H and 39.7 for 13C in 
DMSO-d6). Infrared spectra were recorded with spectrometer FT-IR Nicolet 6700 (Thermo Scientific, 
Waltham, MA, USA) using attenuated total reflectance (ATR) methodology. Melting points were 
assessed by SMP3 Stuart Scientific (Bibby Scientific Ltd., Staffordshire, UK) and were uncorrected. 
Elemental analyses were measured with EA 1110 CHNS Analyzer (Fisons Instruments S. p. A., Carlo 
Erba, Milano, Italy). Calculation of electronic Hammett’s σ parameters was carried out on the software 
ACD/Percepta ver. 2012 (Advanced Chemistry Development, Inc., Toronto, ON, Canada). 
3.2. Starting Compound and Final Products Synthesis 
The starting compound 5-chloro-6-methylpyrazine-2,3-dicarbonitrile was synthesized in a two-step 
reaction according to the reported methodology [30]. The first step was a condensation reaction 
between diaminomaleonitrile (0.025 mol) and pyruvic acid (0.025 mol), which were dissolved in 
methanol (60 mL), and hydrochloric acid (10 mL, 15%) was added dropwise. It takes two hours to 
react at room temperature. After the evaporation of two thirds of the solvent, hot water (80 mL) was 
added and then the rest of methanol was evaporated in vacuo. The whole mixture was cooled to 5 °C to 
initiate the crystallization. The product was collected by suction, dried overnight and subsequently 
chlorinated with phosphoryl chloride. Product (0.015 mol) was again dissolved in POCl3 (0.060 mol) 
and cooled to 0 °C. Pyridine (0.020 mol) was added dropwise and after the termination of the 
exothermic reaction, the mixture was heated to 90 °C for 2 h. Excess POCl3 was evaporated in vacuo 
and the rest of product was extracted into toluene three or four times, the toluene was evaporated and 
then the crude product was recrystallized from chloroform. The starting compound (1.12 mmol) was 
finally treated with 15 variously ring-substituted benzylamines (2.24 mmol) and all these 
aminodehalogenation reactions took place in the microwave reactor. The conditions used for 
microwave syntheses were as follows—150 °C, 30 min, 120 W, methanol as a solvent, pyridine as a 
base and were set experimentally. The reaction was monitored by TLC using hexane/ethyl acetate 2:1 
mixture as mobile phase. The final compounds were purified using flash column chromatography with 
gradient elution using a hexane/ethyl acetate system and if necessary recrystallization from a mixture 
of ethanol and water. 
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3.3. Analytical Data of the Prepared Compounds 
5-Methyl-6-[(2-methylbenzyl)amino]pyrazine-2,3-dicarbonitrile (1). Light orange crystalline solid. 
Yield 47.9%; M.p. 152.1–152.9 °C; IR (ATR-Ge, cm−1): 3381m (-NH-), 2226m (-CN), 1570vs, 1521s, 
1403vs, 1349m (arom.); 1H-NMR (500 MHz) δ 8.61 (1H, bs, NH), 7.25–7.10 (4H, m, H3', H4', H5', 
H6'), 4.56 (2H, s, NCH2), 2.47 (3H, s, CH3), 2.33 (3H, s, CH3); 13C-NMR (125 MHz) δ 152.9, 147.5, 
136.0, 135.6, 130.2, 130.1, 127.5, 127.2, 125.9, 117.4, 115.7, 114.8, 42.5, 21.3, 19.0; Elemental 
analysis: calc. for C15H13N5 (MW 263.12): 68.42% C, 4.98% H, 26.60% N; found 68.22% C,  
5.17% H, 26.44% N. 
5-Methyl-6-{[3-(trifluoromethyl)benzyl]amino}pyrazine-2,3-dicarbonitrile (2). Yellow-orange crystalline 
solid. Yield 51.6%; M.p. 158.5–159.7 °C (decomp.); IR (ATR-Ge, cm−1): 3377m (-NH-), 2227m (-CN), 
1570vs, 1521s, 1402vs, 1353m, 1324vs (arom.), 1128vs (-C-F); 1H-NMR (300 MHz) δ 8.75 (1H, bs, NH), 
7.77–7.60 (1H, m, H2'), 7.68–7.50 (3H, m, H4', H5', H6'), 4.69 (2H, d, J = 4.6 Hz, NCH2), 2.46 (3H, s, 
CH3); 13C-NMR (75 MHz) δ 152.9, 147.7, 139.6, 131.8, 130.0, 129.6, 129.2 (q, J = 31.5 Hz), 124.5 (q, 
J = 4.0 Hz), 124.4 (q, J = 272.3 Hz), 124.0 (q, J = 4.0 Hz), 117.7, 115.6, 114.8, 44.0, 21.2; Elemental 
analysis: calc. for C15H10F3N5 (MW 317.27): 56.78% C, 3.18% H, 22.07% N; found 56.59% C, 3.30% 
H, 21.93% N. 
5-[(3,4-Dichlorobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (3). Light yellow crystalline solid. 
Yield 60.9%; M.p. 154.4–156.2 °C; IR (ATR-Ge, cm−1): 3329m (-NH-), 2227m (-CN), 1568vs, 1516s, 
1466m, 1402vs (arom.); 1H-NMR (300 MHz) δ 8.69 (1H, bs, NH), 7.61 (1H, d, J = 1.9 Hz, H2'), 7.57 
(1H, d, J = 8.2 Hz, H5'), 7.33 (1H, dd, J = 8.2 Hz, J = 1.9 Hz, H6'), 4.59 (2H, s, NCH2), 2.46 (3H, s, 
CH3); 13C-NMR (75 MHz) δ 152.8, 147.8, 139.4, 131.1, 130.6, 130.0, 129.8, 129.6, 127.9, 117.8, 
115.6, 114.8, 43.3, 21.2; Elemental analysis: calc. for C14H9Cl2N5 (MW 318.16): 52.85% C, 2.85% H, 
22.01% N; found 52.71% C, 3.05% H, 21.88% N. 
5-Methyl-6-[(4-methylbenzyl)amino]pyrazine-2,3-dicarbonitrile (4). Light yellow crystalline solid. 
Yield 60.5%; M.p. 140.8–142.3 °C; IR (ATR-Ge, cm−1): 3370s (-NH-), 2223m (-CN), 1576vs, 1519s, 
1438m, 1400vs, 1351s (arom.); 1H-NMR (300 MHz) δ 8.68 (1H, bs, NH), 7.24–7.18 (2H, m, AA', BB', 
H2', H6'), 7.14–7.09 (2H, m, AA', BB', H3', H5'), 4.55 (2H, bs, NCH2), 2.44 (3H, s, CH3), 2.26 (3H, s, 
CH3); 13C-NMR (75 MHz) δ 152.8, 147.5, 136.4, 135.0, 130.1, 128.1, 127.5, 117.3, 115.7, 114.9, 44.1, 
21.2, 20.8; Elemental analysis: calc. for C15H13N5 (MW 263.30): 68.42% C, 4.98% H, 26.60% N; 
found 68.30% C, 5.17% H, 26.43% N. 
5-[(4-Methoxybenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (5). Ochre crystalline solid. Yield 
61.3%; M.p. 153.0–154.2 °C (decomp.); IR (ATR-Ge, cm−1): 3345m (-NH-), 2948w (-OCH3), 2223m  
(-CN), 1585s, 1570vs, 1511vs, 1462m, 1403vs (arom.); 1H-NMR (300 MHz) δ 8.66 (1H, bs, NH),  
7.29–7.23 (2H, m, AA', BB', H2', H6'), 6.90–6.84 (2H, m, AA', BB', H3', H5'), 4.52 (2H, bs, NCH2), 
3.71 (3H, s, OCH3), 2.43 (3H, s, CH3); 13C-NMR (75 MHz) δ 158.6, 152.8, 147.4, 130.1, 129.9, 129.0, 
117.3, 115.7, 114.9, 113.9, 55.2, 43.8, 21.2; Elemental analysis: calc. for C15H13N5O (MW 279.30): 
64.51% C, 4.69% H, 25.07% N; found 64.35% C, 4.81% H, 24.84% N. 
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5-(Benzylamino)-6-methylpyrazine-2,3-dicarbonitrile (6) [30]. Yellow-orange crystalline solid. Yield 
53.3%; M.p. 128.7–130.7 °C (described in the literature 118–119 °C); IR (ATR-Ge, cm−1): 3404m 
(-NH-), 2228m (-CN), 1564vs, 1508vs, 1454m, 1400vs, 1357s (arom.); 1H-NMR (300 MHz) δ 8.72 (1H, 
bs, NH), 7.37–7.20 (5H, m, H2', H3', H4', H5', H6'), 4.61 (2H, d, J = 3.3 Hz, NCH2), 2.45 (3H, s, 
CH3); 13C-NMR (75 MHz) δ 152.9, 147.5, 138.1, 130.1, 128.5, 127.5, 127.2, 117.4, 115.7, 114.9, 44.3, 
21.2; Elemental analysis: calc. for C14H11N5 (MW 249.27): 67.46% C, 4.45% H, 28.10% N; found 
67.21% C, 4.63% H, 27.95% N. 
5-[(4-Aminobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (7). Brown crystalline solid. Yield 
37.2%; M.p. 154.9–156.5 °C; IR (ATR-Ge, cm−1): 3413m (-NH2), 3376m (-NH-), 2234m (-CN), 1572vs, 
1519vs, 1440m, 1402vs, 1352s (arom.); 1H-NMR (300 MHz) δ 8.54 (1H, bs, NH), 7.04–6.94 (2H, m, 
AA', BB', H2', H6'), 6.54–6.45 (2H, m, AA', BB', H3', H5'), 4.97 (2H, bs, NH2), 4.41 (2H, d, J = 3.8 Hz, 
NCH2), 2.41 (3H, s, CH3); 13C-NMR (75 MHz) δ 152.7, 148.0, 147.3, 130.2, 128.7, 124.7, 117.0, 
115.8, 114.9, 113.9, 44.2, 21.2; Elemental analysis: calc. for C14H12N6 (MW 264.29): 63.62% C, 
4.58% H, 31.80% N; found 63.48% C, 4.45% H, 31.65% N. 
5-[(3-Chlorobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (8). Yellow crystalline solid. Yield 
60.2%; M.p. 151.0–151.8 °C; IR (ATR-Ge, cm−1): 3306m (-NH-), 2248m (-CN), 1567vs, 1513vs, 1468m, 
1401vs, 1351s (arom.); 1H-NMR (300 MHz) δ 8.70 (1H, t, J = 5.9 Hz, NH), 7.43–7.39 (1H, m, H2'), 
7.38–7.27 (3H, m, H4', H5', H6'), 4.61 (2H, d, J = 5.9 Hz, NCH2), 2.46 (3H, s, CH3); 13C-NMR  
(75 MHz) δ 152.9, 147.7, 140.7, 133.2, 130.4, 130.0, 127.4, 127.2, 126.2, 117.7, 115.6, 114.9, 43.8, 
21.2; Elemental analysis: calc. for C14H10ClN5 (MW 283.72): 59.27% C, 3.55% H, 24.68% N; found 
59.08% C, 3.71% H, 24.57% N. 
5-[(2-Chlorobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (9). Dark orange crystalline solid. 
Yield 24.7%; M.p. decomp.; IR (ATR-Ge, cm−1): 3381m (-NH-), 2227m (-CN), 1570vs, 1521s, 1474m, 
1440m, 1401s, 1351s (arom.); 1H-NMR (300 MHz) δ 8.68 (1H, bs, NH), 7.51–7.24 (4H, m, H3', H4', 
H5', H6'), 4.66 (2H, s, NCH2), 2.49 (3H, s, CH3); 13C-NMR (75 MHz) δ 153.0, 147.7, 134.9, 132.3, 
130.0, 129.4, 129.1, 128.9, 127.4, 117.8, 115.6, 114.8, 42.4, 21.2; Elemental analysis: calc. for 
C14H10ClN5 (MW 283.72): 59.27% C, 3.55% H, 24.68% N; found 59.08% C, 3.68% H, 24.90% N. 
5-[(2-Fluorobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (10). Dark yellow crystalline solid. 
Yield 60.8%; M.p. 134.8–136.3 °C; IR (ATR-Ge, cm−1): 3377m (-NH-), 2231m (-CN), 1573vs, 1523s, 
1491m, 1402s, 1354s (arom.); 1H-NMR (300 MHz) δ 8.68 (1H, t, J = 5.3 Hz, NH), 7.42–7.10 (4H, m, 
H3', H4', H5', H6'), 4.63 (2H, d, J = 5.3 Hz, NCH2), 2.46 (3H, s, CH3); 13C-NMR (75 MHz) δ 160.0 (d, 
J = 244.8 Hz), 152.9, 147.6, 129.8 (d, J = 20.4 Hz), 129.8, 129.4 (d, J = 8.3 Hz), 124.6 (d, J = 17.8 
Hz), 124.5 (d, J = 6.6 Hz), 117.7, 115.5 (d, J = 9.2 Hz), 115.2, 114.8, 38.3, 21.2; Elemental analysis: 
calc. for C14H10FN5 (MW 267.26): 62.92% C, 3.77% H, 26.20% N; found 62.71% C, 3.59% H, 
26.38% N. 
5-Methyl-6-{[4-(trifluoromethyl)benzyl]amino}pyrazine-2,3-dicarbonitrile (11). Light yellow crystalline 
solid. Yield 38.3%; M.p. 148.4–149.6 °C; IR (ATR-Ge, cm−1): 3397m (-NH-), 2232m (-CN), 1570vs, 
1520s, 1422m, 1399s, 1324vs (arom.), 1114vs (-C-F); 1H-NMR (300 MHz) δ 8.54 (1H, t, J = 5.3 Hz, 
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NH), 7.71–7.64 (2H, m, AA', BB', H2', H6'), 7.38–7.52 (2H, m, AA', BB', H3', H5'), 4.69 (2H, d,  
J = 5.3 Hz, NCH2), 2.51 (3H, s, CH3); 13C-NMR (75 MHz) δ 152.9, 147.7, 143.1, 130.0, 128.2, 127.9 
(q, J = 31.5 Hz), 125.4 (q, J = 3.7 Hz), 124.5 (q, J = 272.0 Hz), 117.8, 115.6, 114.8, 44.0, 21.2; 
Elemental analysis: calc. for C15H10F3N5 (MW 317.27): 56.78% C, 3.18% H, 22.07% N; found 56.59% 
C, 2.99% H, 21.91% N. 
5-Methyl-6-{[2-(trifluoromethyl)benzyl]amino}pyrazine-2,3-dicarbonitrile (12). Yellow-orange crystalline 
solid. Yield 49.1%; M.p. 157.8–159.4 °C (decomp.); IR (ATR-Ge, cm−1): 3408m (-NH-), 2230m (-CN), 
1569vs, 1522s, 1430m, 1409s, 1398s, 1368s, 1314vs (arom.), 1114vs (-C-F); 1H-NMR (300 MHz) δ 8.76 
(1H, bs, NH), 7.77–7.71 (1H, m, H3'), 7.64–7.43 (3H, m, H4', H5', H6'), 4.77 (2H, bs, NCH2),  
2.51 (3H, s, CH3); 13C-NMR (75 MHz) δ 153.0, 147.7, 136.3, 132.9, 130.0, 128.3, 127.8, 126.4 (q,  
J = 30.3 Hz), 126.1 (q, J = 6.0 Hz), 124.7 (q, J = 274.0 Hz), 118.0, 115.5, 114.7, 41.1, 21.2; Elemental 
analysis: calc. for C15H10F3N5 (MW 317.27): 56.78% C, 3.18% H, 22.07% N; found 56.62% C, 3.08% 
H, 22.00% N. 
5-[(2,4-Dimethoxybenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (13). Ochre crystalline solid. 
Yield 62.3%; M.p. 151.6–152.9 °C; IR (ATR-Ge, cm−1): 3336m (-NH-), 2924w (-OCH3), 2224m (-CN), 
1609s, 1574vs, 1509vs, 1467m, 1440s, 1405vs (arom.); 1H-NMR (300 MHz) δ 8.45 (1H, t, J = 5.7 Hz, 
NH), 7.07 (1H, d, J = 8.2 Hz, H6'), 6.55 (1H, d, J = 2.5 Hz, H3'), 6.43 (1H, dd, J = 8.2 Hz, J = 2.5 Hz, 
H5'), 4.47 (2H, d, J = 5.7 Hz, NCH2), 3.80 (3H, s, OCH3), 3.72 (3H, s, OCH3), 2.44 (3H, s, CH3);  
13C-NMR (75 MHz) δ 160.1, 158.1, 153.0, 147.4, 130.2, 128.8, 117.3, 117.2, 115.8, 114.9, 104.6, 
98.5, 55.7, 55.4, 39.5, 21.3; Elemental analysis: calc. for C16H15N5O2 (MW 309.32): 62.13% C, 4.89% 
H, 22.64% N; found 62.36% C, 5.01% H, 22.52% N. 
5-Methyl-6-[(3-nitrobenzyl)amino]pyrazine-2,3-dicarbonitrile (14). Orange-red crystalline solid. Yield 
17.2%; M.p. decomp.; IR (ATR-Ge, cm−1): 3394m (-NH-), 2231m (-CN), 1571vs, 1547m, 1524vs, 1478m, 
1430m, 1396s, 1366s, 1348vs (arom.); 1H-NMR (300 MHz) δ 8.79 (1H, t, J = 5.8 Hz, NH), 8.23 (1H, s, 
H2'), 8.11 (1H, d, J = 7.8 Hz, H4'), 7.81 (1H, d, J = 7.8 Hz, H6'), 7.62 (1H, t, J = 7.8 Hz, H5'), 4.73 
(2H, d, J = 5.8 Hz, NCH2), 2.47 (3H, s, CH3); 13C-NMR (75 MHz) δ 152.9, 148.0, 147.8, 140.6, 134.4, 
130.0, 130.0, 122.5, 122.3, 117.9, 115.6, 114.8, 43.8, 21.2; Elemental analysis: calc. for C14H10N6O2 
(MW 294.27): 57.14% C, 3.43% H, 28.56% N; found 56.93% C, 3.64% H, 28.56% N. 
5-[(4-Chlorobenzyl)amino]-6-methylpyrazine-2,3-dicarbonitrile (15). Brown crystalline solid. Yield 
30.8%; M.p. 152.8–154.8 °C (decomp.); IR (ATR-Ge, cm−1): 3378m (-NH-), 2230m (-CN), 1570vs, 
1521s, 1487m, 1441m, 1403s, 1347s (arom.), 804s (-C-Cl); 1H-NMR (500 MHz) δ 8.42 (1H, bs, NH), 
7.39–7.33 (4H, m, H2', H3', H5', H6'), 4.59 (2H, s, NCH2), 2.45 (3H, s, CH3); 13C-NMR (125 MHz) δ 
152.8, 147.6, 137.2, 131.8, 130.0, 129.4, 128.5, 117.6, 115.6, 114.8, 43.7, 21.2; Elemental analysis: 
calc. for C14H10ClN5 (MW 283.72): 59.27% C, 3.55% H, 24.68% N; found 59.16% C, 3.65% H, 
24.62% N. 
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3.4. Lipophilicity HPLC Determination and Calculations 
Experimental lipophilicity parameter log k was ascertained using an Agilent Technologies 1200 SL 
HPLC system with a SL G1315C Diode-Array Detector, ZORBAX XDB-C18 5 μm, 4 × 4 mm, Part 
No. 7995118-504 chromatographic pre-column and ZORBAX Eclipse XDB-C18 5 μm, 4.6 × 250 mm, 
Part No. 7995118-585 column (Agilent Technologies Inc., Colorado Springs, CO, USA). The 
separation process was controlled by Agilent ChemStation, version B.04.02 extended by spectral 
module (Agilent Technologies Inc.). A solution of MeOH (HPLC grade, 70%) and H2O (HPLC-Milli-
Q Grade, 30%) was used as mobile phase. The total flow of the column was 1.0 mL/min, injection  
20 μL, column temperature 30 °C. Detection wavelength λ= 210 nm and monitor wavelength  
λ= 270 nm were chosen for this measurement. The KI methanol solution was used for the dead time 
(TD) determination. Retention times (TR) of synthesized compounds were measured in minutes. The 
capacity factors k were calculated using Microsoft Excel according to formula k = (TR − TD)/TD, 
where TR is the retention time of the solute and TD denotes the dead time obtained via an unretained 
analyte. Log k, calculated from the capacity factor k, is used as the lipophilicity index converted to  
log P scale. Values of log P and Clog P were calculated with the PC programme CS ChemBioDraw 
Ultra 13.0 (CambridgeSoft, Cambridge, MA, USA). 
3.5. Biological Assays 
3.5.1. Antimycobacterial In Vitro Screening 
Mycobacterial screening was performed against four mycobacterial stems (M. tuberculosis H37Rv 
CNCTC My 331/88, M. kansasii CNCTC My 235/80, M. avium ssp. avium CNCTC My 80/72,  
M. avium CNCTC My 152/73 (Czech National Collection of Type Cultures, National Institute of 
Public Health, Prague, Czech Republic)) using isoniazid and pyrazinamide (Sigma-Aldrich) as 
standards. Culturing medium was Sula’s semisynthetic medium (Trios, Prague, Czech Republic) with 
pH 6.0. Tested compounds were dissolved in dimethylsulfoxide (DMSO) and diluted with medium to 
final concentrations 100, 50, 25, 12.5, 6.25, 3.125 and 1.5625 μg/mL. The method used for this assay 
was microdilution broth panel method. The final concentration of DMSO did not exceed 1% (v/v) and 
did not affect the growth of Mycobacteria. The cultures were grown in Sula’s medium at 37 °C in 
humid dark atmosphere. The antimycobacterial activity was determined using Alamar Blue colouring 
after 14 days, resp. 6 days against M. kansasii, of incubation as MIC (µg/mL). This evaluation was 
done in cooperation with Department of Clinical Microbiology, University Hospital in Hradec 
Kralove, Hradec Kralove, Czech Republic. 
3.5.2. Antimycobacterial In Vitro Screening Against M. smegmatis 
This assay was focused on the activity against fast growing Mycobacterium smegmatis MC2155 
(CIT Collection, Cork Institute of Technology, Cork, Ireland). The method used there was also 
microdilution broth panel method and as the medium was used Middlebrook 7H9 Broth with 10% of 
OADC supplement (Sigma-Aldrich). Tested compounds were dissolved in DMSO and medium and 
the final concentrations were set as 1000, 500, 250, 125, 62.5, 31.25, 15.625 and 7.8125 µg/mL. The 
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final concentration of DMSO did not exceed 2% (v/v) and did not affect the growth of M. smegmatis. 
The standards used for determination of activity were isoniazid and ciprofloxacin. MIC was read after 
48 h of incubation at 37 °C, addition of Alamar Blue stain was followed by 12 h of additional 
incubation with this reagent. This screening was performed under the patronage of the Department of 
Biological Sciences, Cork Institute of Technology, Cork, Ireland. 
3.5.3. Antifungal and Antibacterial In Vitro Screenings 
Antibacterial evaluation was made using the microdilution broth method in plates M27A-M1 
(200+10) against eight bacterial stems from the Czech Collection of Microorganisms (Brno, Czech 
Republic) or clinical isolates from Department of Clinical Microbiology, University Hospital in 
Hradec Kralove (Hradec Kralove, Czech Republic) (Staphylococcus aureus CCM 4516/08, 
Staphylococcus aureus H 5996/08 methicillin resistant, Staphylococcus epidermidis H 6966/08, 
Enterococcus sp. J14365/08, Escherichia coli CCM 4517, Klebsiella pneumoniae D 11750/08, 
Klebsiella pneumoniae J 14368/05 ESBL positive, Pseudomonas aeruginosa CCM 1961). Mueller 
Hinton broth was used for the cultivation that was done in humid atmosphere at 35 °C. The readings 
were made after 24 and 48 h and MIC was set as 80% inhibition of control. The standards were 
neomycin, bacitracin, penicillin G, ciprofloxacin and phenoxymethylpenicillin and tested products 
were dissolved in DMSO (final concentration of DMSO did not exceed 1% (v/v)) [40]. 
Antifungal evaluation was also accomplished with microdilution broth method. On the contrary, 
there was used RPMI 1640 broth with glutamine as medium and conditions were humid and dark 
atmosphere, pH 7.0 (buffered with 3-morpholinopropane-1-sulfonic acid) and 35 °C. Eight fungal 
strains were used (Candida albicans ATCC 44859, Candida tropicalis 156, Candida krusei E28, 
Candida glabrata 20/I, Trichosporon asahii 1188, Aspergillus fumigatus 231, Absidia corymbifera 
272, Trichophyton mentagrophytes 445) together with 4 antimycotic standards amphotericin B, 
voriconazole, nystatin and fluconazole. The MIC was set as 80% inhibition of control and readings were 
made after 24 and 48 h (50% IC, 72 and 120 h for fibrous fungi) and tested compounds were also dissolved 
in DMSO (final concentration of DMSO in medium did not exceed 2.5% (v/v)) [41]. 
3.5.4. Study of the Inhibition of Oxygen Evolution Rate in Spinach Chloroplasts 
Chloroplasts were prepared from spinach (Spinacia oleracea L.) according to Masarovicova and 
Kralova [42]. The inhibition of photosynthetic electron transport (PET) in spinach chloroplasts was 
determined spectrophotometrically (Genesys 6, Thermo Scientific, Madison, WI, USA) using an 
artificial electron acceptor 2,6-dichlorophenol-indophenol (DCPIP) according to Kralova et al. [43] 
and the rate of photosynthetic electron transport (PET) was monitored as a photo-reduction of DCPIP. 
The measurements were carried out in a phosphate buffer (0.02 mol/L, pH 7.2) containing sucrose  
(0.4 mol/L), MgCl2 (0.005 mol/L) and NaCl (0.015 mol/L). The chlorophyll content was 30 mg/L in 
these experiments and the samples were irradiated (~100 W/m2) from a 10 cm distance with halogen 
lamp (250 W) using a 4 cm water filter to prevent warming of the samples (suspension temperature 4 °C). 
The studied compounds were dissolved in DMSO due to their limited water solubility. The applied 
DMSO concentration (up to 4% (v/v)) did not affect the photochemical activity in spinach chloroplasts 
(PET). The inhibitory efficiency of the studied compounds was expressed as the IC50 values, i.e., molar 
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concentration of the compounds causing 50% decrease in the oxygen evolution relative to the 
untreated control. The comparable IC50 value for a selective herbicide 3-(3,4-dichlorophenyl)-1,1-
dimethylurea (Diurone®, DCMU) was about 1.9 μmol/L [44]. 
3.5.5. Study of Fluorescence of Chlorophyll a in Spinach Chloroplasts 
The fluorescence emission spectra of chlorophyll a (Chla) in spinach chloroplasts were recorded on 
fluorescence spectrophotometer F-2000 (Hitachi, Tokyo, Japan) using excitation wavelength λex = 436 nm 
for monitoring fluorescence of Chla, excitation slit 20 nm and emission slit 10 nm. The samples were 
kept in the dark 2 min before measuring. The phosphate buffer used for dilution of the chloroplast 
suspension was the same as described above. Due to low aqueous solubility the compounds were 
added to a chloroplast suspension in DMSO solution. The DMSO concentration in all samples was the 
same as in the control (10% (v/v)). The chlorophyll concentration in chloroplast suspension  
was 10 mg/L. 
4. Conclusions 
A series of 15 pyrazinamide derivatives (14 of them novel) was synthesized by aminodehalogenation 
reactions focusing on microwave assisted synthesis. All the final compounds were characterized with 
IR, NMR and other analytical data and then subjected to in vitro evaluation in order to discover their 
potential antimycobacterial, antifungal, antibacterial and herbicidal activities. 
The lipophilicity was measured using RP-HPLC methodology and also calculated or predicted with 
the PC program CS ChemBioDraw Ultra 13.0. These values were compared and the dependence 
between log k and log P was linear. 
In antimycobacterial screening compounds 3 (R = 3,4-Cl), 9 (R = 2-Cl) and 11 (R = 4-CF3) showed 
good activity against wild strain M. tuberculosis H37Rv (MIC = 6.25 µg/mL) compared to the standards 
pyrazinamide (MIC = 12.5 µg/mL) and isoniazid (MIC = 1.56 µg/mL). Compounds 11 (R = 4-CF3) and 12 
(R = 2-CF3) were active against the non-tuberculosis strains M. kansasii and M. avium as well. 
Although the majority of synthesized compounds were active, there is no clear dependence between 
lipophilicity and antimycobacterial activity, but it can be stated that the most potent substances were 
also from the group of most lipophilic compounds and the most favourable substitutions are the 
electron-withdrawing groups such as chlorine or trifluoromethyl. Activity against fast growing 
Mycobacteria was also determined but no active substances were identified. 
No interesting results were observed in antibacterial and antifungal screenings. Three compounds  
(7 (R = 4-NH2), 10 (R = 2-F), and 15 (R = 4-Cl)) showed insignificant activity against the fungus 
Trichophyton mentagrophytes, which was found to be worse compared to the standards. The rest of 
substances showed no in vitro antibacterial or antifungal activity. 
On the contrary, N-substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles were found to inhibit 
the Hill reaction in spinach chloroplasts which indicated that these compounds act as PS2 inhibitors. 
The IC50 values related to PET inhibition varied in the investigated set in the range from 16.4 μmol/L 
(3; R = 3,4-Cl) to 487.0 μmol/L (14; R = 3-NO2). The lipophilicity of the compounds was determinant 
for PET-inhibiting activity. The site of inhibitory action of studied compounds in the photosynthetic 
apparatus is situated both on the donor and on the acceptor side of PS2. Perturbation of the  
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Chla-protein complexes in the thylakoid membranes caused by the tested compounds was documented 
by a decrease of the Chla emission band intensity at 686 nm belonging to the pigment-protein 
complexes in photosystem 2. 
Based on the obtained results it can be assumed that the antifungal and antibacterial activities of 
studied compounds are not directly dependent on lipophilicity. This conclusion cannot be applied for 
the herbicidal activity because there is a linear dependence between activity and lipophilicity. 
Dependence between antimycobacterial activity and the benzyl substituents was found. This reliance 
was expressed by the lipophilicity parameter log k resp. π constant and showed the importance of the 
ring-substituted benzyl moiety. 
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